Piracetam Human Subjects in Clinical Trials

	A	B
1	Piracetam Clinical Trials
2	Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.	149
3	The impact of stroke on cognitive processing - a prospective event-related potential study.	563
4	Development of a simple chromatographic method for the determination of piracetam in human plasma and its pharmacokinetic evaluation.	18
5	[Clinical research on children mental retardation treated with acupuncture].	60
6	Effect of reinforcing kidney-essence, removing phlegm, and promoting mental therapy on treating Alzheimer's disease.	30
7	[Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].	30
8	Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells.	20
9	Clinical research on comprehensive treatment of senile vascular dementia.	32
10	Cerebroprotective effect of piracetam in patients undergoing open heart surgery	44
11	[Impacts of moxibustion on vascular dementia and neuropeptide substance content in cerebral spinal fluid].	44
12	[Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].	38
13	[Clinical features of the formation and possibilities of treatment of posttraumatic cognitive disturbances].	21
14	Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?	15
15	[Omaron in the complex treatment of patients with multiple sclerosis].	33
16	[Clinical curative effect of Shenxiong Bushen Capsule and its effect on the quality of life of patients with Vascular dementia].	20
17	Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex.
18	Efficacy of akatinol memantine in moderate cognitive impairments.	20
19	[Effects of moxibustion at head-points on levels of somatostatin and arginine vasopressin from cerebrospinal fluid in patients with vascular dementia: a randomized controlled trial].	32
20	[Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].	20
21	[Efficacy of acatinol memantine in mild cognitive disorder].	20
22	Piracetam improves children's memory after general anaesthesia.	123
23	[Dyslexia: clinical, neurophysiological and neuropsychological manifestations during the treatment with nootropil]	18
24	Painful crises in children with sickle cell disease are not prevented by piracetam.
25	[Asthenic syndrome in clinical course of acute period of brain concussion during complex treatment using nootropic agents].	37
26	First preliminary results of an observation of Panax ginseng treatment in patients with autistic disorder.
27	Cerebroprotective effect of piracetam in patients undergoing coronary bypass burgery	60
28	[Atomoxetine and piracetam in the treatment of attention deficit hyperactivity disorder in children].	14
29	Potential efficacy of early treatment of acute acoustic trauma with steroids and piracetam after gunshot noise.	52
30	[Application of nootropic agents in complex treatment of patients with concussion of the brain].	32
31	[The use of enerion in the treatment of asthenic disorders in patients after mild cranio-cerebral trauma].	16
32	The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients.	8
33	A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.	20
34	Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.	20
35	Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage.	50
36	Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease.	5
37	Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.	50
38	[Clastogenic, aneugenic, pro- and antioxidant properties of some neurotropic preparations].
39	[Immunomediation or hyperviscosity in rapidly progressive sensorineural hearing loss. A therapeutic approach].	29
40	Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.	35
41	Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction.	108
42	Clinical observation and mechanism study on treatment of senile dementia with Naohuandan.	28
43	Evaluation of various therapeutic schemes in the treatment of tinnitus due to acute acoustic trauma.	27
44	Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease.	36
45	[Phezam efficacy in patients with chronic cerebral ischemic disease].	60
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100